Skip to main content

MoneyWorks4Me

The sales declined to Rs. 11603.30 millions for the June 2022 quarter as compared to Rs. 12696.90 millions during the corresponding quarter last year.The Company to register a -62.40%  fall in the net profit for the quarter ended June 2022.The Operating Profit of the company witnessed a decrease to 1272.50 millions from 2787.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 11603.30 12696.90 -8.61 11603.30 12696.90 -8.61 49966.00 50514.40 -1.09
Other Income 6.20 41.60 -85.10 6.20 41.60 -85.10 499.80 835.20 -40.16
PBIDT 1272.50 2787.10 -54.34 1272.50 2787.10 -54.34 11044.30 15819.70 -30.19
Interest 87.00 20.30 328.57 87.00 20.30 328.57 166.70 127.70 30.54
PBDT 1185.50 2766.80 -57.15 1185.50 2766.80 -57.15 10877.60 15692.00 -30.68
Depreciation 460.90 434.90 5.98 460.90 434.90 5.98 1793.10 1526.00 17.50
PBT 724.60 2331.90 -68.93 724.60 2331.90 -68.93 9084.50 14166.00 -35.87
TAX 0.00 405.00 0.00 0.00 405.00 0.00 1144.50 2412.10 -52.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 724.60 1926.90 -62.40 724.60 1926.90 -62.40 7940.00 11753.90 -32.45
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 10.97 21.95 -50.04 10.97 21.95 -50.04 22.10 31.32 -29.42
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..